Bruton’s Tyrosine Kinase Inhibitors for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
= .71) was significantly different between groups. BTK inhibitors offer a valuable, safe, and effective treatment option for CSU, particularly in cases that are refractory to second-generation H1 antihistamines.
Authors
- Guilherme Kuceki (ORCID: https://orcid.org/0000-0003-0099-8627)
- Laura Ghanem (ORCID: https://orcid.org/0009-0009-7918-0107)
- Daniela Lucía Mendoza‐Millán (ORCID: https://orcid.org/0000-0003-1481-5166)
- Esteban Fernández Faith (ORCID: https://orcid.org/0000-0002-8641-6730)
- Martin Cevallos-Cueva
- Cristina Sicorschi Gutu (ORCID: https://orcid.org/0009-0003-8998-4519)
- Chinenye Onejeme (ORCID: https://orcid.org/0009-0009-5582-7535)
Institutions
- Nationwide Children's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Central University of Ecuador (EC)
- Lebanese University (LB)
- Ohio Department of Health (US)
- Paracelsus Medizinische Privatuniversität (DE)
- Polyphor (Switzerland) (CH)
Publication Details
- Journal
- Journal of Cutaneous Medicine and Surgery
- Published
- 2026-04-17
- DOI
- https://doi.org/10.1177/12034754261418239
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00